Kai-yun You
Overview
Explore the profile of Kai-yun You including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
182
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
OuYang P, Zhang B, Guo J, Liu J, Li J, Peng Q, et al.
EClinicalMedicine
. 2023 Apr;
58:101930.
PMID: 37090437
Background: Radiotherapy is the mainstay of treatment for nasopharyngeal carcinoma. Radiation-induced temporal lobe injury (TLI) can regress or resolve in the early phase, but it is irreversible at a later...
2.
You K, Bi Z, Ma Y, Mao Y, Zou W, Liu Y, et al.
Cancer Control
. 2021 Feb;
28:1073274821997426.
PMID: 33626920
Purpose: Although breast conservation surgery(BCS) followed by adjuvant radiotherapy is now the mainstream treatment method for breast ductal carcinoma in situ(DCIS), mastectomy is still performed in some patients who refuse...
3.
You K, Zou W, Ding L, Bi Z, Yao H
Cancer Manag Res
. 2021 Feb;
13:1325-1332.
PMID: 33603478
Purpose: The optimum timing of adjuvant radiotherapy for breast cancer patients who had undergone surgery remains unclear. The present study aimed to identify the clinical factors which could assist the...
4.
BRD7 inhibits tumor progression by positively regulating the p53 pathway in hepatocellular carcinoma
Chen C, Mo H, Jiang Y, Zhao X, Ma S, You K, et al.
J Cancer
. 2021 Feb;
12(5):1507-1519.
PMID: 33531996
Bromodomain-containing protein 7 (BRD7) is identified as a transcriptional regulator and plays an important role in the development and progression of various tumors. Our previous study demonstrated that BRD7 acts...
5.
You K, Bi Z, Ding L, Ma Y, Liu Y, Yao H
Cancer Manag Res
. 2020 Oct;
12:9211-9219.
PMID: 33061612
Background: Due to the low rate of regional recurrence (RR) in early-stage breast cancer with pT1-2 and negative sentinel lymph node biopsy (SLNB), no regional therapy is suggested for them....
6.
Shen T, Jiang Y, Zou Y, Qiu F, Qiu X, You K
Radiat Oncol
. 2019 Nov;
14(1):203.
PMID: 31722727
Objective: To determine the prognostic effect of adjuvant radiation and clinicopathological variables in surgically treated patients with small cell carcinoma of the cervix (SCCC). Methods: Clinical data of SCCC patients...
7.
Peng H, Liao Z, Lin X, Qiu X, You K
Cancer Manag Res
. 2019 Jul;
11:5221-5229.
PMID: 31354342
Patients with early-stage distal rectal cancer, if treated with radical surgery, usually suffer a poor quality of life. Definitive radiotherapy or chemoradiotherapy may be another treatment option for them. The...
8.
You K, Peng H, Jiang Y, Bi Z, Qiu X
Cancer Manag Res
. 2019 Jun;
11:4815-4823.
PMID: 31213903
Whether concurrent chemotherapy could bring about better oncological outcomes in elderly patients receiving definitive radiotherapy is still unknown. So, the purpose of this study was to find out whether it...
9.
Peng H, Zhou X, Zhou T, Qiu X, You K
Radiat Oncol
. 2019 Jan;
14(1):8.
PMID: 30651116
Background: The optimal care for pT3N0 rectal cancer remains controversial. And whether tumor location can be used to guide the administration of adjuvant radiotherapy for pT3N0 rectal cancer is not...
10.
OuYang P, You K, Zhang L, Xiao Y, Zhang X, Xie F
Cancer Commun (Lond)
. 2018 Sep;
38(1):55.
PMID: 30176932
Background: The tumor-node-metastasis (TNM) staging system does not perform well for guiding individualized induction or adjuvant chemotherapy for patients with locoregionally advanced nasopharyngeal carcinoma (NPC). We attempted to externally validate...